| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f28d71f9090710f59c9851be4bca17a1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-71 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-71 |
| filingDate |
2019-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a8d8798d4702013713f3383d5ddf17d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31c28bfe8686d19b2033d24fe2017c62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1666353949d9f6742a16801beda308c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e54e3e5b8221bb7a7c536a77d756a40 |
| publicationDate |
2019-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019180719-A1 |
| titleOfInvention |
Nigella sativa oil composition |
| abstract |
The present invention is directed to composition comprising Nigella sativa (NS) oil, wherein said oil comprises thymoquinone (TQ) at a concentration of at least 2% (w/w). The composition is further characterized by having a much lower free fatty acid concentration than prior art compositions. The composition, which has anti-inflammatory activity, may be formulated for oral administration to a mammalian subject, for the purpose of preventing or treating inflammatory conditions and other disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020157748-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022254446-A1 |
| priorityDate |
2018-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |